Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 86-92

  Asai, Masami ^a   Kato, Masashi ^a   Asai, Naoya ^a   Iwashita, Toshihide ^a   Murakami, Hideki ^a   Kawai, Kumi ^a   Nakashima, Izumi ^a   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Malignant melanoma; MMP 9; RET; TIMP 2; Transgenic mice

Indexed keywords

COLLAGENASE; GELATINASE B; MATRILYSIN; METALLOTHIONEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MALIGNANT TRANSFORMATION; MELANOMA; MELANOSIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSGENE; WESTERN BLOTTING;

EID: 0033006939     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00670.x     Document Type: Article

References (18)

1. Iwamoto, T., Takahashi, M., Ito, M., Hamatani, M., Ohbayashi, M., Wajjwalku, W., Isobe, K. and Nakashima, I. Aberrant melanogenesis and melanocytic tumor development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J., 10, 3167-3175 (1991).
2. v mice. Exp. Cell Res., 200, 410-415 (1992).
3. Takahashi, M., Iwamoto, T. and Nakashima, I. Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice. Pigment Cell Res., 5, 344-347 (1992).
4. Kato, M., Takahashi, M., Akhand, A. A., Liu, W., Shimizu, S., Iwamoto, T., Suzuki, H. and Nakashima, I. Transgenic mouse model for skin malignant melanoma. Oncogene, 17, 1885-1888 (1998).
5. Asai, N., Iwashita, T., Matsuyama, M. and Takahashi, M. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol., 15, 1613-1619 (1995).
6. Sakata, K., Kozaki, K., Iida, K., Tanaka, R., Yamagata, S., Utsumi, K. R., Saga, S., Shimizu, S. and Matsuyama, M. Establishment and characterization of high-and low-lung-metastatic cell lines derived from murine colon adenocarcinoma 26 tumor line. Jpn. J. Cancer Res., 87, 78-85 (1996).
7. Higashino, F., Yoshida, K., Norumi, T., Seiki, M. and Fujinaga, K. Ets-related protein EIA-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-1463 (1995).
8. Bernhard, E. J., Muschel, R. J. and Hughes, E. N. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50, 3872-3877 (1990).
9. Houde, M., De Bruyne, G., Bracke, M., Ingelman-Sundberg, M., Skoglund, G., Masure, S., Van Damme, J. and Opdenakker, G. Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human bowes melanoma cells. Int. J. Cancer, 53, 395-400 (1993).
10. Hujanen, E. S., Vaisanen, A., Zheng, A., Tryggvason, K. and Turpeenniemi-Hujanen, T. Modulation of Mr 72,000 and Mr 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma. Int. J. Cancer, 58, 582-586 (1994).
11. Kawashima, A., Nakanishi, I., Tsuchiya, H., Roessner, A., Obata, K. and Okada, Y. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor α correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch., 424, 547-552 (1994).
12. MacDougall, J. R., Bani, M. R., Lin, Y., Rak, J. and Kerbel, R. S. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res., 55, 4174-4181 (1995).
13. Gouon, V., Tucker, G. C., Kraus-Berthier, L., Atassi, G. and Kieffer, N. Up-regulated expression of the β3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice. Int. J. Cancer, 68, 650-662 (1996).
14. van den Oord, J. J., Paemen, L., Opdenakker, G. and De Wolf-Peeters, C. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am. J. Pathol., 151, 665-670 (1997).
15. Stetler-Stevenson, W. G., Krutzsch, H. C. and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem., 264, 17374-17378 (1989).
16. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y. and Seiki, M. Activation of the precursor of gelatinise A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer, 64, 355-359 (1995).
17. Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler-Stevenson, W. G. and Seiki, M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1 matrix metalloproteinase. FEBS Lett., 385, 238-240 (1996).
18. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y. Sato, H., Seiki, M. and Okada, Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res., 56, 2707-2710 (1996).